SteriMax Inc. has acquired Andone Pharmaceuticals Inc., a Canadian pharmaceutical and medical device company based in Oakville, Ontario. The acquisition strengthens SteriMax’s position as one of the largest privately owned Canadian pharmaceutical companies and broadens its platform into the medical device and veterinary markets.

Founded by Jay Barat, Andone was established with a simple mission: to help healthcare professionals spend less time managing operational challenges and more time delivering patient care. As a team, Andone identified opportunities to simplify day-to-day practice through innovative, practical solutions. What began with a focus on acute care evolved into a diversified business serving pharmaceutical, homecare, veterinary, and medical device markets across Canada.

Andone’s three commercial verticals – pharmaceuticals, medical devices, and veterinary – complement SteriMax’s existing injectable portfolio and customer base, while providing established platforms for growth in the veterinary and medical device sectors.

As part of the transaction, Andone founder Jay Barat joins SteriMax to lead its veterinary and medical device businesses.

“Bringing Andone and its team into SteriMax accelerates our expansion into adjacent markets where we see strong long-term growth,” said Samir Acharya, President and CEO of SteriMax. “Our combined portfolios, expertise, and customer relationships position us to better serve healthcare providers across a broader spectrum of care.”

“I am proud of what the Andone team has built,” said Jay Barat. “Joining SteriMax accelerates our ability to grow, expand our portfolio, and better serve our customers. Our organizations share a commitment to quality, innovation, and customer service, and I look forward to building on that foundation together.”